Ein selbstassoziierender difunktioneller Rezeptor

Durch Komplexierung eines Na+ ‐Ions „einschalten”︁ läßt sich die Fähigkeit des Kationenrezeptors 1, eines Calixarens, Wasserstoffbrückenbindungen zwischen der Diamidopyridingruppe und einer komplementären Gruppe wie Thymin zu bilden. Ist diese ihrerseits an einen Anionenrezeptor (z.B. ein metalliertes Porphyrin) gebunden, erhält man einen nichtkovalent zusammengesetzten, difunktionellen Rezeptor, in dem Kation und Anion eines anorganischen Salzes wie NaSCN gleichzeitig komplexiert vorliegen

Effect of a high surface-to-volume ratio on fluorescence-based assays

In the work discussed in this paper, the effect of a high surface-to-volume ratio of a microfluidic detection cell on fluorescence quenching was studied. It was found that modification of the geometry of a microchannel can provide a wider linear range. This is a phenomenon which should be taken into consideration when microfluidic systems with fluorescence detection are developed. The dependence of the linear range for fluorescein on the surface-to-volume ratio was determined. Both fluorescence inner-filter effects and concentration self-quenching were taken into consideration. It was found that inner-filter effects have little effect on the extent of the linear range on the microscale. [Figure: see text

Why Can Organoids Improve Current Organ-on-Chip Platforms?

Preclinical studies are the first stage of introducing a new potential drug to the pharmaceutical market. Many of the compounds with promising results approved in the preclinical stage show poor prognosis during the first stage of clinical studies, which is connected with inadequate in vitro and in vivo models used in this stage. Both basic in vitro models, and in vivo animal models do not represent the human conditions. Therefore, scientists work on creating an appropriate model that will highly reproduce the characteristics of the human body. The solution could be an organoids model: a laboratory-produced human miniature organ, grown in a specially designed Organ-on-Chip microfluidic tools. This review focuses on characterizing the 3D cell culture types, focusing mainly on organoids, the Organ-on-Chip approach, and presenting the latest reports about the application of their combination in biological research, including toxicological studies

Why Can Organoids Improve Current Organ-on-Chip Platforms?

Preclinical studies are the first stage of introducing a new potential drug to the pharmaceutical market. Many of the compounds with promising results approved in the preclinical stage show poor prognosis during the first stage of clinical studies, which is connected with inadequate in vitro and in vivo models used in this stage. Both basic in vitro models, and in vivo animal models do not represent the human conditions. Therefore, scientists work on creating an appropriate model that will highly reproduce the characteristics of the human body. The solution could be an organoids model: a laboratory-produced human miniature organ, grown in a specially designed Organ-on-Chip microfluidic tools. This review focuses on characterizing the 3D cell culture types, focusing mainly on organoids, the Organ-on-Chip approach, and presenting the latest reports about the application of their combination in biological research, including toxicological studies.</jats:p